Publications by authors named "Zaidoun Salah"

37Publications

MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma.

Int J Cancer 2019 12 9;145(11):3052-3063. Epub 2019 May 9.

The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, The Hebrew University-Hadassah Medical School at Ein-Kerem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32368DOI Listing
December 2019

WW-Domain Containing Protein Roles in Breast Tumorigenesis.

Front Oncol 2018 13;8:580. Epub 2018 Dec 13.

Al Quds-Bard College for Arts and Sciences, Al Quds University, Abu Dis, Palestine.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fonc.2018.00580/
Publisher Site
http://dx.doi.org/10.3389/fonc.2018.00580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300493PMC
December 2018

Anticancer Activity, Antioxidant Activity, and Phenolic and Flavonoids Content of Wild Plant Extracts.

Evid Based Complement Alternat Med 2016 24;2016:9612490. Epub 2016 Nov 24.

Al-Quds-Bard College, Al-Quds University, Abu Dies, East Jerusalem, State of Palestine.

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/ecam/2016/9612490/
Publisher Site
http://dx.doi.org/10.1155/2016/9612490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143780PMC
November 2016

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.

Oncotarget 2015 Mar;6(7):4920-35

The Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467124PMC
http://dx.doi.org/10.18632/oncotarget.3025DOI Listing
March 2015

Protease-activated-receptor 1 polymorphisms correlate with risk for unexplained recurrent pregnancy loss: a pilot study querying an association beyond coagulation.

Eur J Obstet Gynecol Reprod Biol 2015 Feb 25;185:13-8. Epub 2014 Nov 25.

Department of Oncology and Tumor Biology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2014.11.021DOI Listing
February 2015

The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.

Oncotarget 2014 Nov;5(21):10886-900

The Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel. Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279417PMC
http://dx.doi.org/10.18632/oncotarget.2540DOI Listing
November 2014

WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.

Proc Natl Acad Sci U S A 2014 Nov 20;111(44):E4716-25. Epub 2014 Oct 20.

The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1409252111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226089PMC
November 2014

The WWOX gene modulates high-density lipoprotein and lipid metabolism.

Circ Cardiovasc Genet 2014 Aug 28;7(4):491-504. Epub 2014 May 28.

From the Cardiovascular Research Laboratories, Department of Biochemistry, Faculty of Medicine, Division of Cardiology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada (I.I., H.Y.C., I.R., Z.A., J.G.); Department of Human Genetics (M.V.P.L.R., D.W.-V., E.N., P.P.) and Department of Medicine (M.V.P.L.R., D.W.-V., E.N., P.P.), David Geffen School of Medicine at University of California at Los Angeles; Department of Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Smithville (H.K., J.L., C.M.A.); The Lautenberg Cancer Research Center, Department of Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel (M.A.O., M.A.-R., R.I.A.); The Lautenberg Center for Immunology and Cancer Research, Department of Immunology and Cancer Research-IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel and Al-Quds-Bard College for Arts and Sciences, Al-Quds University, East Jerusalem-Abu Dis, Palestine (Z.S.); and Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus (M.C., C.M.C., R.I.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCGENETICS.113.000248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315188PMC
August 2014

Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

J Biol Chem 2014 Mar 18;289(13):8865-80. Epub 2014 Feb 18.

From the Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel 91120.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M113.506790DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979411PMC
March 2014

NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.

Cell Cycle 2013 Dec 7;12(24):3817-23. Epub 2013 Oct 7.

The Lautenberg Center for Immunology and Cancer Research; IMRIC; Hebrew University-Hadassah Medical School; Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cc.26672
Publisher Site
http://dx.doi.org/10.4161/cc.26672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905073PMC
December 2013

Characterization of WWOX inactivation in murine mammary gland development.

J Cell Physiol 2013 Jul;228(7):1391-6

Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.24310DOI Listing
July 2013

A molecular epidemiology survey of respiratory adenoviruses circulating in children residing in Southern Palestine.

PLoS One 2012 3;7(8):e42732. Epub 2012 Aug 3.

Virology Research Laboratory, Medical Research Center, Al-Quds University , East Jerusalem-Abu Dies, Palestine.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0042732PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411832PMC
January 2013

Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors.

J Mol Biol 2012 Sep 23;422(1):58-74. Epub 2012 May 23.

Department of Biochemistry and Molecular Biology, Leonard Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmb.2012.05.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412936PMC
September 2012

miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Cancer Res 2012 Apr 20;72(7):1865-77. Epub 2012 Feb 20.

Department of Orthopaedics and Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-2663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328547PMC
April 2012

Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen.

FASEB J 2012 May 30;26(5):2031-42. Epub 2012 Jan 30.

Sharett Institute of Oncology, Hadassah-Hebrew University Hospital, P.O. Box 12000, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.11-194704DOI Listing
May 2012

WW domain-containing proteins: retrospectives and the future.

Front Biosci (Landmark Ed) 2012 Jan 1;17:331-48. Epub 2012 Jan 1.

The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/3930DOI Listing
January 2012

PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway.

IUBMB Life 2011 Jun 9;63(6):397-402. Epub 2011 May 9.

Department of Oncology, Sharett Institute, Hadassah University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/iub.452DOI Listing
June 2011

Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

Cancer Res 2011 Mar 6;71(5):2010-20. Epub 2011 Jan 6.

The Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-3516DOI Listing
March 2011

Cell death or survival promoted by alternative isoforms of ErbB4.

Mol Biol Cell 2010 Dec 13;21(23):4275-86. Epub 2010 Oct 13.

Department of Medical Biochemistry and Genetics, and Medicity Research Laboratory, University of Turku, Turku, Finland; Department of Oncology, Turku University Hospital, FIN-20520 Turku, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1091/mbc.E10-04-0332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993754PMC
December 2010

WWOX gene and gene product: tumor suppression through specific protein interactions.

Future Oncol 2010 Feb;6(2):249-59

The Lautenberg Center for Immunology, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Pharmacy Building, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.09.152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832309PMC
February 2010

WWOX: its genomics, partners, and functions.

J Cell Biochem 2009 Nov;108(4):737-45

The Lautenberg Center for General and Tumor Immunology, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.22298DOI Listing
November 2009

Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer.

Cancer Res 2007 Oct;67(20):9835-43

Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-1886DOI Listing
October 2007

Association study of protease activated receptor 1 gene polymorphisms and adverse pregnancy outcomes: results of a pilot study in Israel.

Am J Med Genet A 2007 Nov;143A(21):2557-63

Department of Obstetrics & Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.31985DOI Listing
November 2007

Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression.

Mol Cancer Res 2007 Mar;5(3):229-40

Department of Oncology, Hadassah-Hebrew University Hospital, P.O. Box 12000, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-06-0261DOI Listing
March 2007

The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma.

Gynecol Oncol 2006 Dec 27;103(3):802-6. Epub 2006 Jul 27.

Department of Oncology, Hadassah-Hebrew University Hospital, POB 12000, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.05.048DOI Listing
December 2006

Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.

Int J Cancer 2005 Jan;113(3):372-8

Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.20607DOI Listing
January 2005

The pattern of expression of protease-activated receptors (PARs) during early trophoblast development.

J Pathol 2003 May;200(1):47-52

Department of Oncology, Pathology, Hadassah University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1338DOI Listing
May 2003

Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness.

Arterioscler Thromb Vasc Biol 2003 Jun 13;23(6):940-4. Epub 2003 Mar 13.

Department of Oncology, Hadassah-University Hospital, POB 12000, Jerusalem 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.ATV.0000066878.27340.22DOI Listing
June 2003

Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation.

FASEB J 2003 Feb;17(2):163-74

Department of Oncology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.02-0316comDOI Listing
February 2003